Benzinga | May 7, 2021 07:29AM EDT

HC Wainwright & Co. Maintains Buy on Zymeworks, Lowers Price Target to $55

HC Wainwright & Co. analyst Robert Burns maintains Zymeworks (NYSE:ZYME) with a Buy and lowers the price target from $57 to $55.